Search

everythinglearnresearchcommunity

for

Search:↓

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The hair test for vitamin D could be a useful alternative to blood tests, providing a longer-term vitamin D status, but more research is needed.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Testosterone undecanoate safely and effectively increased penis size in male children with 5-alpha-reductase deficiency.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

The normal human prostate does not significantly affect blood DHT levels.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The study created a new method to test drugs that affect hormone processing in skin.

DHT deficiency increases iNOS expression in rat testis and epididymis.

The woman's symptoms and tests suggest her adrenal glands are producing too many male hormones.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

The assay effectively detects hormonal activity of certain chemicals.

High DHEA-S levels may cause hair loss in young men.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.